Healthcare Financial News

You worked hard during your working years to create a retirement corpus. Now, it is time to deploy the retirement corpus smartly so that you can enjoy the golden years without any financial worries. In this article, we will understand what the 3-bucket strategy for retirement is and how to go about it. Also Read: Retirement Planning: Securing Your Future with Free DematAccounts

Sectorally, buying was seen in metals, healthcare, and public sector while selling was seen in realty, capital goods and telecom indices which were down more than 1% each.

ARTPARK is not just a regular park in your neighbourhood. For tech enthusiasts, it’s an ecosystem fostering inclusivity and driving equitable access to artificial intelligence (AI) and robotics solutions. Established in 2020 within the Indian Institute of Science (IISc) campus in Bengaluru, ARTPARK is India’s first AI and robotics technology hub. “ARTPARK aims to develop world-class critical technologies for robotics and autonomous systems, reduce India’s import footprint in them and catalyse AI for India’s big challenges,” said Raghuram Dharmaraju, chief executive of ARTPARK. At its core, ARTPARK, a non-profit organisation, is a nexus for innovation, uniting startups, industry leaders, researchers, government bodies and non-profits. It also aims to skill the next generation of professionals in advanced manufacturing for robotics and autonomous technologies by 2025.

Health Insurance for senior citizens: The recent amendments by the Insurance Regulatory and Development Authority of India (IRDAI) regarding health insurance rules are set to benefit senior citizens significantly. By removing the age ceiling of 65 years for purchasing health insurance, IRDAI has expanded access to health insurance products for individuals of various age groups. Previously, seniors above 65 years could still buy health coverage, but options were limited in the market.

Delhi…May 3, 2024…KARAM Safety, a leading global PPE player and fall protection solutions provider, is pleased to announce the successful acquisition of Midas Safety India, a prominent player in the hand protection safety products industry. This strategic move marks a significant milestone in KARAM Group's journey towards expanding its presence and enhancing its product offerings.

Coforge chief executive Sudhi Singh on Friday said it will shell out $220 million, or about Rs 1,826 crore, to acquire 54% stake in Hyderabad-based Cigniti Technologies even as the Noida-based IT firm launched an open offer to acquire an additional 26% stake in Cigniti. Coforge had on Thursday said it is acquiring 54% share in Cigniti from promoters and other shareholders at Rs 1,415 per share.

₹17,000 crore, amounting to 60-70% of its capital expenditure requirement. The loan, from a consortium led by India's largest lender SBI, will be part of a financial closure programme for Adani Petrochemicals Ltd’s coal-to-polyvinyl chloride plant, which would be India's largest PVC manufacturing facility once completed. The group had in March last year halted the project saying it had decided to hold major equipment procurement and site construction activities pending financial closure, following the Hindenburg report that had alleged financial fraud at Adani Group companies.

National Nurses Week is celebrated annually in May and some food outlets provide unique and amazing deals for this particular week.

healthcare system grapples with fragmented patient data, leading to suboptimal care outcomes as providers often lack access to medical histories. However, the Ayushman Bharat Digital Mission (ABDM), initiated in 2021, has the potential to revolutionise this scenario by: Providing unique health IDs, ABHA (Ayushman Bharat Health Account), to individuals. Establishing verified registries for hospitals and healthcare providers.

Sudhir Singh, CEO, Coforge, says “the retail vertical of the merged entity is going to be operating almost immediately at about $100 million per annum. The healthcare and the high-tech verticals of the merged entity from day one will be operating at about 50 million US dollars, in some cases more than that as well.” You have announced your largest ever acquisition, which is going to add about 20% to your top line, but the Street is worried that you have bitten more than you can chew with the execution risk. Help us understand the strategic rationale behind this buy. Sudhir Singh: We think this acquisition is fundamentally a game changer for Coforge going forward. This acquisition does three important things for us. Number one, it will allow us to stand up three new industry verticals. The retail vertical of the merged entity is going to be operating almost immediately at about $100 million per annum. The healthcare and the high-tech verticals of the merged entity from day one will be operating at about 50 million US dollars, in some cases more than that as well, so that is number one.

₹659 in September 2021 following strong results in the June 2021 quarter (Q1FY22) during which it clocked 34% volume growth year-on-year. Ignoring that it had come off a low base owing to the impact of the covid-19 pandemic in the base quarter, investors extrapolated such strong growth would continue well into the future. This optimism has come at a cost, as the stock price still lags nearly 15% below its peak even after almost three years.

Companies continued rewarding investors with healthy dividends in 2023 even as they tread more cautiously with returning profits through stock buybacks

The way the pot can't call the kettle black, hardly any product seller or service provider can take the 'holier than thou' stance against others. The Supreme Court's rebuke to the Indian Medical Association (IMA) during the Patanjali misleading advertising case hearing, asking it to also put its house in order, given the complaints of unethical conduct by allopathic doctors, is an instance in point here. Lack of effective regulations and their poor implementation is one of the major reasons for consumers' disempowerment over the years. Regular instances of product contamination, deficiency in services and involuntary product recalls or bans ordered by other countries point to the lack of regulatory deterrence among Indian businesses.

Coforge on 2 May approved the acquisition of a 54 per cent stake in IT major Cigniti Technologies at a per share price of ₹1,415, the company said in its regulatory filing. The firm added that the acquisition process is expected to be completed by Q2FY25, subject to regulatory approvals by SEBI. The firm believes that the acquisition of Cigniti will not only help it grow to US$ 2 billion by FY27 but, ensure that the Coforge’s operating margins improve by 150-200 bps by FY27 itself.

₹358.80 a share on the NSE on Thursday, down 1.98%, while the Nifty index closed at 22,648.20 points. Its total market capitalization stood at ₹4,997.71 crore. CVC Capital Partners, which purchased around 59% in Healthcare Global for ₹1,100 crore in 2020, raised its shareholding to over 60.4% later.

Vadilal Industries Ltd.(up 6.16%), Future Consumer Ltd.(up 5.56%), Dabur India Ltd.(up 3.46%), Varun Beverages Ltd.(up 2.53%), Gillette India Ltd.(up 1.56%), Tasty Bite Eatables Ltd.(up 1.49%), Dodla Dairy Ltd.(up 1.38%), Bajaj Consumer Care Ltd.(up 1.33%), Jyothy Labs Ltd.(up 1.16%) and Godrej Consumer Products Ltd.(up 1.14%) stood among the top gainers.

CVS Health missed first-quarter expectations and chopped its 2024 outlook more than a dollar below Wall Street’s forecast

The beginning of the Change Healthcare cyberattack happened when hackers entered a server that lacked multifactor authentication

Amkay Products IPO: From price band to GMP - here's everything you need to know In the fiscal years ending December 31 of 2021, 2022, and 2023, the revenue generated from manufacturing operations was ₹3,020.24 lakh, ₹2,255.89 lakh, and ₹2,224.59 lakh, respectively. Concurrently, revenue from branding and trading operations for the same periods stood at ₹1049.71 lakh, ₹1394.48 lakh, ₹561.83 lakh, and ₹437.71 lakh, respectively. The Amkay Products IPO was subscribed over 32.61 times on the first day of subscription.

Quality Assurance: At Gary Pharma, quality is at the core of everything we do. We follow stringent quality control measures at every stage of the manufacturing process to ensure that our derma products meet the highest standards of safety, efficacy, and purity. From sourcing raw materials to conducting rigorous quality checks, we leave no stone unturned in delivering products that instill trust and confidence among healthcare professionals and patients alike.

Securing the future of both women and their families hinges significantly on the pivotal role of health. In the diverse tapestry of India, women adeptly navigate the intricate balance between their professional aspirations and familial responsibilities, epitomising resilience and adaptability.